Submitting Documents Using Real-World Data and Real-World Evidence to FDA for Drug and Biological Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 9, 2022
March 15, 2023
42c343c9-e823-43a4-a2f7-a2fe152b02aa
Related Documents
Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products
Guidance DocumentMay 26, 2023Center for Drug Evaluation and Research
Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment: Guidance for Industry; Availability
Guidance DocumentOctober 17, 2022Office of the Commissioner
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
Guidance DocumentJuly 27, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.